Archit Organosys (BOM:524640) Marketable Securities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524640 Archit Organosys Ltd BOM:524640
63 GF Score
Price ₹62.14
GF Value ₹55.84
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Archit Organosys Marketable Securities?

Archit Organosys BOM:524640 -4.69% 63 Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:524640 with a GF Score™ of 63/100 and a GF Value™ of ₹55.84 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Archit Organosys's Marketable Securities for the quarter that ended in Jun. 2026 was ₹0 Mil.

Archit Organosys's annual Marketable Securities declined from Mar. 2024 (₹3 Mil) to Mar. 2025 (₹2 Mil) but then increased from Mar. 2025 (₹2 Mil) to Mar. 2026 (₹9 Mil).

Archit Organosys  (BOM:524640) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Archit Organosys Marketable Securities Related Terms

Archit Organosys Marketable Securities Historical Data

* Premium members only.

The historical data trend for Archit Organosys's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Archit Organosys Marketable Securities Chart

Archit Organosys Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 3.56 2.56 1.93 8.83

Archit Organosys Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 5.96 0.00 8.83 0.00
BOM:524640
63GF Score
Archit Organosys Ltd BOM:524640
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Archit Organosys Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0 Mil mean?
Archit Organosys (BOM:524640) has a Marketable Securities of ₹0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Archit Organosys and its competitors.
Is Archit Organosys' Marketable Securities too high?
Archit Organosys' current Marketable Securities is ₹0 Mil. Overall, Archit Organosys has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Archit Organosys' Marketable Securities compare to DOW?
Archit Organosys' Marketable Securities of ₹0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Chemicals company?
A good Marketable Securities depends on the Chemicals industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Archit Organosys and its competitors. Archit Organosys's current Marketable Securities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Archit Organosys stock overvalued right now?
Based on GuruFocus' analysis, Archit Organosys (BOM:524640) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹55.84, compared to a current price of ₹62.14 — trading 11.3% above its estimated fair value. The current Marketable Securities is ₹0 Mil. Archit Organosys' overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Archit Organosys (BOM:524640), the current Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Archit Organosys (BOM:524640) Overvalued in 2026?

Based on GuruFocus' analysis, Archit Organosys stock appears to be overvalued. The current stock price of ₹62.14 is trading 11.3% above its estimated GF Value™ of ₹55.84. GuruFocus considers Archit Organosys to be Modestly Overvalued.

Key valuation signals for BOM:524640:

  • Marketable Securities: ₹0 Mil
  • GF Value™: ₹55.84 vs. price of ₹62.14 (11.3% above fair value)
  • GF Score™: 63/100 with 8 warning signs

No single metric tells the full story. See the BOM:524640 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Archit Organosys Business Description

Address S. G. Highway, 9th Floor, Venus Benecia, Near Pakwan Restaurant, Bodakdev, Ahmedabad, GJ, IND, 380054
Archit Organosys Ltd is mainly engaged in the manufacturing and selling of various chemical products, including alkali chemicals, inorganic chemicals, organic chemicals, pesticides and insecticides, dyes, and dyestuff. The company mainly manufactures and trades chemicals such as Monochloro Acetic Acid (MCA), Sodium Monochloro Acetate (SMCA), Chloroacetyl Chloride, and Trichloroacetyl Chloride (TCAC). It operates in a single segment identified as manufacturing and trading of dyes, chemicals, and pigments. Geographically, it derives the majority of its revenue from India and also exports products to other countries.
63GF Score

Get the complete analysis for BOM:524640

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹62.14
Price
₹55.84
GF Value